FDA Import Refusal 1FX-0338932-8/10002/7 — Sun Pharmaceutical Industries (Prev. Ranbaxy)
The FDA refused shipment 1FX-0338932-8/10002/7 from Sun Pharmaceutical Industries (Prev. Ranbaxy) (India) on Sep 22, 2026. The refused product falls under Drugs and Biologics — DABIGATRAN ETEXILATE MESYLATE (ANTI-COAGULANT). Cited charge: 27 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- Sep 22, 2026
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 61LCA41 DABIGATRAN ETEXILATE MESYLATE (ANTI-COAGULANT)
- Charges
- 27